Delivery Order SPE2DB22D3016-SPE2DB24FBAJ0

Award Date 7/8/24
Potential Completion Date 7/29/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,743.80 firm fixed-price delivery order is for 240 mg/24 ml vials of the drug Opdivo, with a period of performance through November 28, 2023. The contract is not designated as a set-aside and represents an award under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,782.51 firm fixed-price delivery order is for OPDIVO 240 MG/24 ML VIAL 24ML and has an ultimate completion date of April 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 that serves as a primary vehicle for providing a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $24,446.28 firm fixed-price contract is for the delivery of 240 mg/24 ml vials of the drug Opdivo. The order has an ultimate completion date of November 3, 2023. AmerisourceBergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,875.72 delivery order is for OPDIVO 240 MG/24 ML VIAL 24ML and has a firm fixed price. The contract has an ultimate completion date of February 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,647.40 firm fixed price delivery order is for the provision of 240 mg/24 mL vials of the pharmaceutical drug OPDIVO. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,906.79 firm fixed-price delivery order is for the supply of 240 mg/24 ml vials of the medication Opdivo, with a period of performance through May 1, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $93,090.96 delivery order is for the supply of Opdivo 240 mg/24 ml vials. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $15,294.80 firm fixed price delivery order is for the supply of 24 ml vials of the pharmaceutical product Opdivo. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,813.58 fixed-price contract is for the delivery of 240 mg/24 ml vials of the medication Opdivo. The contract has an ultimate completion date of June 12, 2025 and is not a set-aside award. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OPDIVO 240 MG/24 ML VIAL 24ML. The $75,466.88 firm fixed price delivery order has a completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBAJ0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the prescription drug Opdivo (240 mg/24 ml vial). The firm-fixed-price, $15,294.80 delivery order contract has a completion date of July 29, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was not set aside for any particular business type.

Generated 10/7/24, 10:53 AM